C.F. (Tel – Aviv) 2292/04 and C.F. (Tel – Aviv) 1080/05 Merck & Co. Inc., v. Teva Pharmaceutical Industries, Unipharm Ltd. et. al.

The District Court of Tel Aviv set a precedent upon holding that the owner of an accepted patent application under opposition proceedings could not use the unjust enrichment ground for an infringement suit. The Supreme Court upheld the decision.